133 related articles for article (PubMed ID: 9479361)
1. [Effectiveness of treatment with native alpha-interferon (Wellferon) in patients with chronic myeloid leukemia].
Rukavitsyn OA
Vopr Onkol; 1997; 43(6):606-9. PubMed ID: 9479361
[No Abstract] [Full Text] [Related]
2. [Treatment of chronic myeloid leukemia with interferon-alpha].
Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha lymphoblastoid in chronic myeloid leukemia patients unresponsive to recombinant IFN alpha 2.
Steegmann JL; Granados E; Peñarrubia MJ
Haematologica; 1997; 82(6):731-2. PubMed ID: 9580090
[No Abstract] [Full Text] [Related]
4. [The effectiveness of interferon-alpha therapy in Ph-positive chronic myeloid leukemia].
Bogdanov KV; Frolova OI; Marinets OV; Ogorodnikova IuS; Afanas'ev BV; Zaritskiĭ AIu
Vopr Onkol; 2003; 49(2):189-92. PubMed ID: 12785203
[TBL] [Abstract][Full Text] [Related]
5. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
Canales MA; Martínez J; Quevedo E; Hernández-Navarro F
Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
[No Abstract] [Full Text] [Related]
6. [Interferon-alpha in the treatment of chronic myeloid leukemia].
Guilhot F
Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
[No Abstract] [Full Text] [Related]
7. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
Mesquita MM; Pestana A; Mota A
Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
[No Abstract] [Full Text] [Related]
8. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
[TBL] [Abstract][Full Text] [Related]
9. [Alpha-interferons in the treatment of patients with chronic myeloid leukemia].
Abdulkadyrov KM; Udal'eva VIu; Rukavitsyn OA; Bessmel'tsev SS
Vopr Onkol; 1999; 45(4):387-92. PubMed ID: 10532097
[TBL] [Abstract][Full Text] [Related]
10. [Treatment with lymphoblastoid alpha interferon in patients with chronic myeloid leukemia refractory to recombinant interferon alpha 2].
Steegmann JL; Granados E; Vázquez L; de la Cámara R; Peñarrubia MJ; Fernández-Contreras E; Quiroga JA; Fernández Rañada JM
Sangre (Barc); 1998 Oct; 43(5):443-6. PubMed ID: 9868341
[TBL] [Abstract][Full Text] [Related]
11. Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia.
Steegmann JL; Moreno G; Aláez C; Osorio S; Granda A; de la Cámara R; Arranz E; Reino FG; Salvanés FR; Fernández-Rañada JM; Muñoz C
Haematologica; 2003 Jul; 88(7):762-8. PubMed ID: 12857554
[TBL] [Abstract][Full Text] [Related]
12. [Results of imatinib therapy in late-stage chronic myeloid leukemia after treatment with interferon-alpha].
Molnár L; Nagy A; Dávid M; Szomor A; Méhes G; Kovács G; Losonczy H
Orv Hetil; 2004 Apr; 145(17):901-7. PubMed ID: 15170967
[TBL] [Abstract][Full Text] [Related]
13. Does interferon-a exert an anti-leukemic effect by enhancing cell mediated immunity in chronic myeloid leukemia?
Muretto P; Tomassoni S; Staccioli MP; Tabellini L; D'Adamo F; Delfini C
Haematologica; 2000 Feb; 85(2):212-3. PubMed ID: 10681734
[No Abstract] [Full Text] [Related]
14. [Monitoring of Ph chromosome by fluorescence in situ hybridization in chronic myeloid leukemia].
Takahashi N; Miura I
Rinsho Ketsueki; 2000 Apr; 41(4):272-4. PubMed ID: 10846453
[No Abstract] [Full Text] [Related]
15. [Preliminary results of interferon alpha treatment for patients with chronic myelogenous leukemia].
Popławska-Szczygłowska L; Starzyńska J; Chmarzyńska-Mróz E
Pol Tyg Lek; 1996 May; 51(19-22):283-4. PubMed ID: 9289711
[No Abstract] [Full Text] [Related]
16. Imatinib mesylate in Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon alpha.
Tóthová E; Kafková A; Fricová M; Benová B; Kirschnerová G; Tóthová A
Neoplasma; 2005; 52(1):63-7. PubMed ID: 15739029
[TBL] [Abstract][Full Text] [Related]
17. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
[TBL] [Abstract][Full Text] [Related]
18. [Alpha interferon in children with Philadelphia chromosome-positive chronic myeloid-leukaemia].
Ben Lakhal R; Aissaoui L; Jeddi R; Ayari B; Ben Abid H; Belhadj Ali Z; Gouider E; Meddeb B; Hafsia R; Hafsia A
Tunis Med; 2005 May; 83(5):296-9. PubMed ID: 16044905
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha: mechanisms of action in chronic myelogenous leukemia in chronic phase.
Guilhot F; Lacotte-Thierry L
Hematol Cell Ther; 1998 Oct; 40(5):237-9. PubMed ID: 9844819
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinib.
Roche-Lestienne C; Darré S; Laï JL; Facon T; Guilhot J; Preudhomme C
Haematologica; 2005 Jan; 90(1):131-3. PubMed ID: 15642682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]